Zusammenfassung
Die Beeinflussung der Serum-Lipidzusammensetzung durch Steroidhormone stellt ein lange bekanntes und unter vielen Aspekten auch heute noch ungelöstes Problem dar. Im Zusammenhang mit dieser Frage sind zunächst die Östrogene und ihre Derivate überprüft worden. Erst in den vergangenen Jahren hat man sich mit größerer Aufmerksamkeit den Wirkungen der Gestagene und Steroid-kombinationen zugewandt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Alvarez De RR, Gaiser DF, Simkins DM, Smith EK, Bratvold GE (1959) Serial studies of serum lipids in normal human pregnancy. Am J Obstet Gynecol 77:743
Aurell M, Cramer K, Rybo G (1966) Serum lipids and lipoproteins during long-term administration of an oral contraceptive. Lancet 1:291
Bailey JM (1965) Lipid metabolism in cultured cells. Exp Cell Res 37:175
Barr DP, Russ EM, Eder HA (1951) Protein-lipids relationships in human plasma. Am J Med 11:480
Bondjers G, Bjorkerud S (1975) HDL dependent elimination of cholesterol from human arterial tissue. Proc Eur Soc Clin Invest 9:51
Boyd GS (1973) Oestrogens, cholesterol metabolism and atherosclerosis. In: van Keep PA, Lauritzen C (eds) Ageing and estrogens. Karger, Basel, p 74
Bradley DD, Wingerd J, Petitti DB, Krauss MD, Ramcharan S (1978) Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. N Engl J Med 299:17
Brown MS, Kovanen PT, Goldstein JL (1981) Regulation of plasma cholesterol by lipoprotein receptors. Science 212:628
Furman RH, Schettler FG, Boyd GD (1969) Atherosclerosis. Elsevier, Amsterdam London New York
Glueck CJ, Fallat R (1974) Gonadal hormones and triglycerides. Proc R Soc Med 67:667
Gofman JW, Young W, Tandy R (1966) Ischemic heart disease atherosclerosis and longevity. Circulation 34:679
Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) High density lipoprotein as a protective factor against coronary heart disease. The Framingham study. Am J Med 62:707
Hazzard WR (1977) Primary type III hyperlipoproteinemia. In: Rifkind BM, Levy PJ (eds) Hyperlipidemia. Diagnosis and therapy. New York
Hervey E, Hervey GR (1967) The effects of progesterone on body weight and composition in the rat. J Endocrinol 37:361
Jaisle F (1972) Lipide während der Schwangerschaft und Niederkunft. Karger, Basel
Kalkhoff RK (1982) Metabolic effects of progesterone. Am J Obstet Gynecol 142:735
Kay CR (1982) Progestogens and arterial disease. Evidence from the Royal College of General Practitioners study. Am J Obstet Gynecol 142:762
Kenagy R, Weinstein I, Heimberg M (1981) The effects of 17ß-estradiol and progesterone on the metabolism of free fatty acid by perfused livers from normal female and ovarectomized rats. Endocrinology 108:1616
Kim HJ, Kalkhoff RK (1975) Sex steroid influence in triglyceride metabolism. J Clin Invest 56:888
Kim HJ, Kalkhoff RK (1979) Changes in lipoprotein composition during the menstrual cycle. Metabolism 28:663
Knopp RH, Walden CE, Wahl PW (1981) Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: Relationships to estrogen and progestin potency. J Clin Endocrinol Metab 53:1123
Knopp RH, Walden CE, Wahl PW, Hoover JJ (1982) Effects of oral contraceptives in lipoprotein triglyceride and cholesterol: Relationships to estrogen and progestin potency. Am J. Obstet Gynecol 142: 725
Miller GJ, Miller NE (1975) Plasma-high-density-lipoprotein concentration and development of ischemic heart disease. Lancet 1:16
Nikkila E (1953) Studies on the lipid-protein relationship in normal and pathological sera and the effect of heparin or serum lipoproteins. Scand J Clin Lab Invest 5 (Suppl): 8
Oster P, Arab L, Kohlmeier M, Mordasini R, Schellenberg B, Schlierf G (1982) Effects of estrogens and progestogens on lipid metabolism. Am J Obstet Gynecol 142:773
Patt V (1970) Ovarialfunktion und Coronarsklerose. II: Lipidstoffwechsel. Gynäkologe 2:131
Rozenbaum H (1982) Relationships between chemical structure and biological properties of progestogens. Am J Obstet Gynecol 142:719
Salans LB (1971) Influence of progestin and estrogen on fat cell size, number glucose metabolism and insulin sensitivity. Proc 53 Meeting Endocr Soc San Francisco A, p 59
Stokes T, Wynn V (1971) Serum-lipids in women on oral contraceptives. Lancet II: 677
Winkel CA, Snyder JM, MacDonald PC, Simpson ER (1980) Regulation of cholesterol and progesterone synthesis in human placental cells in culture by serum lipoproteins. Endocrinology 106:1054
Wynn V, Doar JWH, Mills GL (1966) Fasting serum triglycerides, cholesterol and lipoprotein levels during oral contraceptive therapy. Lancet 11:756
Wynn V, Niththyananthan R (1982) The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins. Am J Obstet Gynecol 142:766
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Patt, V. (1984). Grundlagen der hormonellen Beeinflussung des Lipidstoffwechsels. In: Bolt, H.M. (eds) Gestagene in oralen Kontrazeptiva. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-52237-6_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-52237-6_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-13516-6
Online ISBN: 978-3-642-52237-6
eBook Packages: Springer Book Archive